ZetaGen Therapeutics

Health Care, Medical Device, Therapeutics
Founded in 1/1/15
Syracuse, New York, United States
http://www.zetagen.com/
For Profit

About ZetaGen Therapeutics

ZetaGen Therapeutics is commercializing a small molecule-based osteoinductive platform technology to develop bone growth products that activate a novel molecular pathway. Discovered serendipitously, ZetaGen's products have the potential to transform the treatment of bone-related injuries, procedures, and diseases to deliver better outcomes for patients, doctors, and payors.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 14200360 USD
  • Last Funding: 9634360 USD (Venture - Series Unknown)
  • Funding Status:

Technology Stack

ZetaGen Therapeutics actively uses None products in their tech stack.

Market Presence

Industries: Health Care, Medical Device, Therapeutics

Headquarters: Syracuse, New York, United States

Leadership

Employees

  • Bryan Margulies - Chief Scientific Officer and Co-founder (LinkedIn)